{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T02:16:00Z","timestamp":1760235360231,"version":"build-2065373602"},"reference-count":35,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2021,8,21]],"date-time":"2021-08-21T00:00:00Z","timestamp":1629504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>In 2012, the Japanese Society for Dialysis Therapy (JSDT) established the order of correction of P, corrected Ca (cCa), and whole PTH (w-PTH) in the treatment of Chronic Kidney Disease-Metabolic Bone Disorder (CKD-MBD) as P-first. However, there is no report that analyzes whether this rule is in line with reality and what the adequate rate of P is. Therefore, we analyzed the test values of our 48 patients during the year of 2019 and examined the validity of the results. The results showed that the adequate range rates were 70.8% for P, 100% for cCa, and 89.6% for w-PTH. This result is better than the JSDT Web-based Analysis of Dialysis Data Archives (WADDA) P adequacy rate of 66.2%. Although the guideline is P-first, it is often the case that we cannot reach the adequate level; therefore, healthcare professionals and patients often blame each other. We believe that this is due to the mismatch between the modern era of processed foods covered with P additives and treatment methods (P intake restriction and P-binders). The development of processed foods with P additives has brought light and darkness to mankind. The light side is freedom from starvation, and the dark side is a new condition caused by P burden: P burden disease including CKD-MBD.<\/jats:p>","DOI":"10.3390\/nu13082874","type":"journal-article","created":{"date-parts":[[2021,8,22]],"date-time":"2021-08-22T21:47:52Z","timestamp":1629668872000},"page":"2874","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A New Disease Concept in the Age of Processed Foods\u2014Phosphorus-Burden Disease; including CKD\u2013MBD Concrete Analysis and the Way to Solution"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0628-322X","authenticated-orcid":false,"given":"Keizo","family":"Nishime","sequence":"first","affiliation":[{"name":"Department of Nephrology, Rakuwakai Nijo Ekimae Clinic, 3 Higashitoganoo-cho, Nishinokyo, Nakagyo Ward, Kyoto City 604-8414, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Sugiyama","sequence":"additional","affiliation":[{"name":"Department of Medical Information, Rakuwakai Headquarters, 51-7 Otowa Hachinotubo, Yamashina Ward, Kyoto City 607-8064, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Okada","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Dialysis Surgery, Rakuwakai Otowa Memorial Hospital, 29-1 Otowachinjyucho, Yamashina Ward, Kyoto City 607-8116, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,8,21]]},"reference":[{"key":"ref_1","unstructured":"(2021, July 10). Available online: https:\/\/www.mhlw.go.jp\/toukei\/saikin\/hw\/jinkou\/suii09\/deth8.html."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Scandinavian Simvastin Survival Study Group (1994). Randamised trial of cholesterol lowering in 4444 patients with coronary heart disease:the Scandinavian Simvastatin Survival Study(4S). Lancet, 344, 1383\u20131389.","DOI":"10.1016\/S0140-6736(94)90566-5"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1080\/14740338.2018.1476487","article-title":"Current and potential treatment options for hyperphosphatemia","volume":"17","author":"Carfagna","year":"2018","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"203","DOI":"10.5551\/jat.RV17045","article-title":"Phosphate as a Pathogen of Arteriosclerosis and Aging","volume":"28","year":"2021","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1210\/jcem-70-5-1334","article-title":"Persistently elevated parathyroid hormone secretion and action in young women after four weeks of ingesting high phosphorus, low calcium diets","volume":"70","author":"Calvo","year":"1990","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s13730-016-0225-2","article-title":"Acute tumoral calcinosis due to severe hyperphosphatemia in a maintenance hemodialysis patient","volume":"5","author":"Nishime","year":"2016","journal-title":"CEN Case Rep."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1053\/ajkd.1998.v32.pm9820470","article-title":"Clinical epidemiology of cardiovascular disease in chronic renal disease","volume":"32","author":"Foley","year":"1998","journal-title":"Am. J. Kidney Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.1161\/01.RES.87.7.e10","article-title":"Phosphate regulation of vascular smooth muscle cell calcification","volume":"87","author":"Jono","year":"2000","journal-title":"Circ. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.2215\/CJN.01660309","article-title":"Phosphate Levels and Cardiovascular Disease in the General Population","volume":"4","author":"Foley","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1681\/ASN.2004070602","article-title":"Serum phosphate levels and mortality risk among people with chronic kidney disease","volume":"16","author":"Kestenbaum","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.3945\/ajcn.2008.26665","article-title":"Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease?","volume":"88","author":"Shinaberger","year":"2008","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/1744-9987.12030","article-title":"Committee of Renal Data Registry of the Japanese Society for Dialysis Therapy. Serum phosphate and calcium should be primarily and consistently controlled in prevalent hemodialysis patients","volume":"17","author":"Taniguchi","year":"2013","journal-title":"Ther. Apher. Dial."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1073\/pnas.101545198","article-title":"Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia","volume":"98","author":"Shimada","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/01.mnh.0000232885.81142.83","article-title":"Klotho as a regulator of fibroblast growth factor signaling and phosphate\/calcium metabolism","volume":"15","year":"2006","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_15","first-page":"812","article-title":"Spironolactone ameliorates PiT1-dependent vascular osteoinduction in klotho-hypomorphic mice","volume":"123","author":"Voelkl","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_16","first-page":"3622","article-title":"Spironolactone dose-dependently alleviates the calcification of aortic rings cultured in hyperphosphatemic medium with or without hyperglycemia by suppressing phenotypic transition of VSMCs through downregulation of Pit-1","volume":"19","author":"Wang","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1159\/000355728","article-title":"25-Hydroxyvitamin D3 1-\u03b1-hydroxylase-dependent stimulation of renal klotho expression by spironolactone","volume":"37","author":"Alesutan","year":"2013","journal-title":"Kidney Blood Press. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jacc.2013.09.056","article-title":"Spironolactone reduces cardiovascular and Cerebrovascular morbidity and mortality in hemodialysis patients","volume":"63","author":"Matsumoto","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_19","first-page":"49","article-title":"Phosphate additives in food\u2014A health risk","volume":"109","author":"Ritz","year":"2012","journal-title":"Dtsch. Arztebl. Int."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.semnephrol.2012.12.018","article-title":"Management of natural and added dietary phosphorus burden in kidney disease","volume":"26","author":"Cupisti","year":"2013","journal-title":"Semin. Nephrol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1053\/j.jrn.2015.12.004","article-title":"Reexamining the Phosphorus-Protein Dilemma: Does Phosphorus Restriction Compromise Protein Status?","volume":"26","author":"Woolf","year":"2016","journal-title":"J. Ren. Nutr."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s11914-017-0398-4","article-title":"Effects of Excessive Dietary Phosphorus Intake on Bone Health","volume":"15","author":"Colby","year":"2017","journal-title":"Curr. Osteoporos. Rep."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/j.jrn.2016.09.007","article-title":"Phosphate-Containing Prescription Medications Contribute to the Daily Phosphate Intake in a Third of Hemodialysis Patients","volume":"27","author":"Nelson","year":"2017","journal-title":"J. Ren. Nutr."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jcmgh.2016.09.010","article-title":"Review: Pathophysiology of Intestinal Na+\/H+ Exchange","volume":"3","author":"Gurney","year":"2017","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1681\/ASN.2018080832","article-title":"Efficacy and Safety of Tenapanor in Patients with Hyperphosphatemia Receiving Maintenance Hemodialysis: A Randomized Phase 3 Trial","volume":"30","author":"Block","year":"2019","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"eaam6474","DOI":"10.1126\/scitranslmed.aam6474","article-title":"Inhibition of sodium\/hydrogen exchanger 3 in the gastrointestinal tract by tenapanor reduces paracellular phosphate permeability","volume":"10","author":"King","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00424-018-2221-1","article-title":"The role of SLC34A2 in intestinal phosphate. absorption and phosphate homeostasis","volume":"471","author":"Marks","year":"2019","journal-title":"Pflugers. Arch."},{"key":"ref_28","unstructured":"(2021, July 31). Dopps Practice Monitor-Hemodialysis. Available online: https:\/\/www.dopps.org\/DPM-HD\/Default.aspx."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2215\/CJN.06080809","article-title":"Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease","volume":"5","author":"Gutekunst","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00418-018-1711-8","article-title":"Dietary phosphate toxicity: An emerging global health concern","volume":"150","author":"Erem","year":"2018","journal-title":"Histochem. Cell Biol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Shutto, Y., Shimada, M., Kitajima, M., Yamabe, H., and Razzaque, M.S. (2011). Lack of awareness among future medical professionals about the risk of consuming hidden phosphate-containing processed food and drinks. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0029105"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1053\/j.jrn.2017.08.013","article-title":"The Impact of Additives on the Phosphorus, Potassium, and Sodium Content of Commonly Consumed Meat, Poultry, and Fish Products Among Patients with Chronic Kidney Disease","volume":"28","author":"Parpia","year":"2018","journal-title":"J. Ren. Nutr."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1053\/j.jrn.2010.06.021","article-title":"Extra-phosphate load from food additives in commonly eaten foods: A real and insidious danger for renal patients","volume":"21","author":"Benini","year":"2011","journal-title":"J. Ren. Nutr."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1681\/ASN.2010020221","article-title":"CRIC Study Group. Low socioeconomic status associates with higher serum phosphate irrespective of race","volume":"21","author":"Anderson","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_35","first-page":"19","article-title":"Klotho, Ageing, Bone and FGF23","volume":"38","year":"2017","journal-title":"Circ. Control."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/13\/8\/2874\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:48:36Z","timestamp":1760165316000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/13\/8\/2874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,21]]},"references-count":35,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8]]}},"alternative-id":["nu13082874"],"URL":"https:\/\/doi.org\/10.3390\/nu13082874","relation":{},"ISSN":["2072-6643"],"issn-type":[{"type":"electronic","value":"2072-6643"}],"subject":[],"published":{"date-parts":[[2021,8,21]]}}}